logo
Select company
Select metric
$ 67.58MCore Assets
VS
Market
23
Sector
46
Industry
53
History
78
$ 3.41Close
$ 0.9 - $ 3.41 52-Week Range
Ticker Information

Ticker

ARMP

Company Name

ARMATA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

ARMATA PHARMACEUTICALS INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARMP - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 80.79M$ 9.72M$ 67.58M$ 3.49M
3/31/2025$ 87.25M$ 17.08M$ 66.68M$ 3.49M
12/31/2024$ 86.44M$ 14.77M$ 68.18M$ 3.49M
9/30/2024$ 98.24M$ 22.62M$ 72.13M$ 3.49M
6/30/2024$ 108.31M$ 31.89M$ 72.94M$ 3.49M
3/31/2024$ 120.36M$ 43.34M$ 73.53M$ 3.49M
12/31/2023$ 98.36M$ 19.24M$ 75.63M$ 3.49M
9/30/2023$ 112.76M$ 29.78M$ 79.49M$ 3.49M
6/30/2023$ 101.21M$ 18.18M$ 79.55M$ 3.49M
3/31/2023$ 108.78M$ 30.83M$ 74.46M$ 3.49M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARMATA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Core Assets stands at $ 25.1M.
  • Over the past 5 years, ARMATA PHARMACEUTICALS INC's average Core Assets has been $ 57.45M.
  • The median Core Assets for ARMATA PHARMACEUTICALS INC during this period was $ 67.13M
  • ARMATA PHARMACEUTICALS INC reached its highest Core Assets over the past 5 years at $ 79.55M.
  • The lowest Core Assets recorded by ARMATA PHARMACEUTICALS INC in the same timeframe $ 25.1M

ARMATA PHARMACEUTICALS INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
CBUS : CIBUS INC $ 44.63MACOG : ALPHA COGNITION INC $ 5.26MPYXS : PYXIS ONCOLOGY INC $ 108.52MORMP : ORAMED PHARMACEUTICALS INC $ 145.89MNTRB : NUTRIBAND INC $ 1.23MPSTV : PLUS THERAPEUTICS INC $ 7.34MDYAI : DYADIC INTERNATIONAL INC $ 4.16MALGS : ALIGOS THERAPEUTICS INC $ 115.94MTCRX : TSCAN THERAPEUTICS INC $ 124.14MIMDX : INSIGHT MOLECULAR DIAGNOSTICS INC $ 9.93M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ARMATA PHARMACEUTICALS INC is calculated as follows: Assets [ $ 45.67M ] - Intangibles [ $ 3.49M ] - CashnEq [ $ 17.09M ]
(=) Core Assets [ $ 25.1M ]

ARMP - Core Assets, Last 5 years

$ 25.1M

Minimum

Sep 30, 2020

$ 79.55M

Maximum

Jun 30, 2023

$ 57.45M

Average

$ 67.13M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 799.74M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.38B
average$ 799.74M
median$ 287.51M
std$ 1.05B